MCK Q2 2019 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q2 2019 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$53.1B+1.9% YoY

Gross Profit

$2.7B5.1% margin

Operating Income

$771M1.5% margin

Net Income

$499M0.9% margin

EPS (Diluted)

$2.51

QoQ Revenue Growth

+0.9%

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.3B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61.4B

Total Liabilities

$50.5B

Stockholders' Equity

$9.3B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53.1B	$52.1B	+1.9%
Gross Profit	$2.7B	$2.7B	-0.9%
Operating Income	$771M	$825M	-6.5%
Net Income	$499M	$1M	+49800.0%

Revenue Segments

U.S. Pharmaceutical Segment

$41.6B96%

Medical-Surgical Solutions Segment

$1.9B4%

Geographic Segments

UNITED STATES

$43.8B82%

International Segment

$9.3B18%